For: | Zhang Y, Meng F, Jin J, Wang J, Gu BB, Peng JB, Ye LP. Ninety-four thousand-case retrospective study on antibacterial drug resistance of Helicobacter pylori. World J Clin Cases 2021; 9(35): 10838-10849 [PMID: 35047595 DOI: 10.12998/wjcc.v9.i35.10838] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i35/10838.htm |
Number | Citing Articles |
1 |
Faming Yang, Baiyang Yu, Lang Qin, Xiaorong Dai. A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori. Medicine 2023; 102(41): e35610 doi: 10.1097/MD.0000000000035610
|
2 |
Ting-Ting Huang, Yong-Xiao Cao, Lei Cao. Novel therapeutic regimens against Helicobacter pylori: an updated systematic review. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1418129
|
3 |
Yifan Lin, Yongfu Shao, Jianing Yan, Guoliang Ye. Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice. Journal of Clinical Laboratory Analysis 2023; 37(7) doi: 10.1002/jcla.24885
|
4 |
Tao Lyu, Ka Shing Cheung, Zijie Deng, Li Ni, Chuan Chen, Juan Wu, Wai K. Leung, Wai Kay Seto. Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin. Helicobacter 2023; 28(4) doi: 10.1111/hel.12972
|
5 |
Jia-Yue Wang, Xian-Zhu Zhou, Chan-Juan Wang, Shi-Han Xu, Hui-Yun Zhu, Yi-Qi Du. Helicobacter pylori antibiotic resistance in different regions of China: A systematic review and meta-analysis. World Chinese Journal of Digestology 2024; 32(1): 71 doi: 10.11569/wcjd.v32.i1.71
|